NCT07130799View on ClinicalTrials.gov

Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

March 1, 2027

Conditions

Intra-abdominal InfectionCritical IllnessPost-Op InfectionImmunization; SepsisCandida Sepsis

Interventions

OTHER

Immunomonitoring

To analyse monocyte HLA-DR expression (mHLA-DR) and CD4+ T lymphocyte count (CD4) in both group

Trial Locations (1)

54500

Central Hospital, Vandœuvre-lès-Nancy

All Listed Sponsors

collaborator

Hospices Civils de Lyon

OTHER

lead

Central Hospital, Nancy, France

OTHER

NCT07130799 - Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection | Biotech Hunter | Biotech Hunter